Global /South Korea /Healthcare /Medical Care Facilities /187660

Penetrium Bioscience Inc.

187660

• KRX: 187660 • Delayed

12,100KRW -3.3%

7.89 USD

As of 6 June 2026, Penetrium Bioscience Inc. has a market cap of $432.3M USD, ranking #16145 globally and #499 in South Korea. It ranks #1457 in the Healthcare sector, and #163 in the Medical Care Facilities industry.

Global Rank

16145

Country Rank

499

Sector Rank

1457

Industry Rank

163

Key Stats

Market Cap

$432.3MUSD

662.64B KRW

Enterprise Value

$434.42MUSD

665.89B KRW

Revenue (TTM)

$6.36MUSD

9.74B KRW

EBITDA (TTM)

-$9.4MUSD

-14.41B KRW

Net Income (TTM)

-$13.11MUSD

-20.1B KRW

EBITDA Margin

-148%

Profit Margin

-206%

PS Ratio

68.0

PB Ratio

100.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Hyun-woo Kim open_in_new

Employees

160

Founded

2003

Website

penetriumbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	5.7%	11%	327%	327%	426%	640%	1K%	41%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	187660 현대에이디엠바이오(주) Ordinary Shares ISIN: KR7187660006 Shares Out.: Shares Outstanding: 54.783M¹ Shares Float: 33.748M² TV: TradingView: KRX: 187660 SA: Stock Analysis: KRX: 187660 YF: Yahoo Finance: 187660.KS GF: Google Finance: KRX: 187660 BA: Barron's: 187660 MS: Morningstar: XKRX: 187660	12,100 KRW	TV: TradingView: KRX: 187660 SA: Stock Analysis: KRX: 187660 YF: Yahoo Finance: 187660.KS GF: Google Finance: KRX: 187660 BA: Barron's: 187660 MS: Morningstar: XKRX: 187660

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Penetrium Bioscience Inc.

Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea. The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. It also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services. The company was formerly known as Hyundai ADM Bio Inc. and changed its name to Penetrium Bioscience Inc. in March 2026. Penetrium Bioscience Inc. was founded in 2003 and is based in Seoul, South Korea.

Similar Companies

Industry: Medical Care Facilities (South Korea)

Name	Market Cap (USD) diff.	PE	Country
HK inno.N Corp. KRX: 195940	$1.0B 1.54T KRW 132%	37.4	South Korea
JS Link, Inc. KRX: 127120	$925.02M 1.42T KRW 114%	-	South Korea
Genomictree Inc. KRX: 228760	$274.11M 420.17B KRW -37%	-	South Korea
HansBiomed Corp. KRX: 042520	$273.54M 419.28B KRW -37%	-	South Korea
U2Bio Co., Ltd. KRX: 221800	$187.62M 287.58B KRW -57%	-	South Korea
GC Genome Corp. KRX: 340450	$133.93M 205.29B KRW -69%	46.9	South Korea

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 54K%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 22K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 6K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 6K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 5K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 5K%	24.6	United States

chevron_leftBack